Now Aceepting Tricare, Triwest, and Medicare for Spravato!

 

We’re thrilled to announce we can now treat Tricare, Triwest, and Medicare patients with Spravato—a breakthrough prescription nasal spray for treatment-resistant depression. Here are a few things everyone should know about Spravato Esketamine Nasal Spray…

 

• Spravato is the first and only nasal spray approved by the FDA for patients with Treatment-Resistant Depression.
• Spravato is a type of Ketamine.
• Spravato works on a different neurotransmitter than traditional antidepressants called glutamate (which can lead to increased neuroplasticity).
• If you’ve tried therapy, medication and other treatments for depression without relief, Ketamine Treatment might be right for you. 

 

 

Spravato Is Covered By Most Major Insurance Companies

 

For patients at New U Therapy & Family Services who have expressed interest in the transformative benefits of Ketamine, this is an exciting step forward! We understand that the cost of care can be a consideration, and this expanded coverage means that more individuals can now access the benefits of Spravato treatment while utilizing their insurance coverage.

 

Our commitment to your well-being drives us to continually seek innovative solutions that empower you on your journey toward mental wellness. If you or someone you know has been navigating the complexities of treatment-resistant depression, we invite you to explore this innovative treatment that offers new hope and healing.